Antifungal composition with enhanced bioavailability

Details Antifungal composition with enhanced bioavailability Antifungal composition with enhanced bioavailability

1997-05-21

1998-11-10

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

5147723, A61K 3150, A61K 31495

Patent

active

058344721

ABSTRACT:
A pharmaceutical composition comprising:

REFERENCES:
patent: 4791111 (1988-12-01), Heeres et al.
patent: 4853223 (1989-08-01), Graf et al.
patent: 4883808 (1989-11-01), Fodor et al.
patent: 4906478 (1990-03-01), Valentine et al.
patent: 5039676 (1991-08-01), Saksena et al.
patent: 5272137 (1993-12-01), Blase et al.
patent: 5411745 (1995-05-01), Oshlack et al.
patent: 5506248 (1996-04-01), Nikafar et al.
patent: 5580578 (1996-12-01), Oshlacket
patent: 5661151 (1997-08-01), Saksena et al.
Yamasaki et. al. Chemical Abstracts vol. 121: 117721u, 1994.
Jon E. Lutz et al., Activity of the Triazole 56592 against Disseminated Murine Coccidioidomycosis, Antimicrobial Agents and Chemotherapy, Jul. 1997, pp. 1558-1561.
Peter G. Welling, Pharmacokinetics, Processes and Mathematics, American Chemical Society, Washington, DC, ACS Monograph 185, (1986), p. 57.
J.G. nairn, Remington's Pharmaceutical Sciences, 18th edition, (1990), Mack Publishing Co., Chapter 83, p. 1519.
A.A. Nomeir et al., Bioavailability of SCH56592, a new broad spectrum triazole antifungl agent, from various formulations; Abstract of paper presented at 36th ICAAC, New Orleans, Louisiana, (Sep. 15-18, 1996); 1 page.
Pluronic.RTM. and Tetronic.RTM. Surfactants, publication of BASF Corporation, Mount Olive, New Jersey (1989), 29 pages.
Pluronic.RTM.Block Copolymer NF Grade (Poloxamer NF Grades); Technical Bulletin of BASF Corporation, (1995), 2 pages.
W. C. Gunsel and J. L. Kanig, Chapter 11, Tablets from The Theory and Practice of Industrial Pharmacy, 2nd Edition, Lea&Febiger, Philadelphia, (1976), pp. 321-344.
Van Hostetler and J.Q. Bellard, Chapter 13, Part I. Hard Tablets, from The Theory and Practice of Industrial Pharmacy, 2nd Edition, Lea&Febiger, Philadelphia, 1976, pp. 389-404.
A. K. Saksena et al., Concise Asymmetric Routes to 2,2,4-Trisubstituted Tetrahydrofurans via Chiral Titanium Imide Enolates: Key Intermediates Towards Synthesis of Highly Active Azole Antifungals SCH51048 and SCH56592, Tetrahedron Letters, vol. 37, No. 32, (1996), pp. 5657-5660.
D. Loebenberg et al., #46, Formulation studies with SCH56592, a new broad spectrum antifungal triazole, abstract of paper submitted at "Focus on Fungal Infections 6" in New Orleans, Louisiana, Mar. 6-8, 1996, 4 pages.

Affiliated with

Also associated with

Rating

Antifungal composition with enhanced bioavailability does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antifungal composition with enhanced bioavailability, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antifungal composition with enhanced bioavailability will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1517010